Summary
The four permanent human glioma-derived cell lines reported here are the first such lines for which the karyotypes have been followed from the original biopsies through the establishment of the lines in culture. Although ploidy changes were seen, each line retained either distinctive marker chromosomes or the overall original chromosomal distribution allowing the origin of each line to be established with certainty. D-263 MG expresses glial fibrillary acidic protein, all lines except D-245 MG are tumorigenic in athymic mice, and each line displays a unique pattern with respect to in vitro growth parameters and expression of biochemically defined markers, oncofetal antigens and lymphoid-associated markers. D-245 MG and D-259 MG are able to grow in the absence of supplemental glutamine; glutamine synthetase was detected in these cell lines both by immunocytochemistry and by direct assay. Thus, the four permanent human glioma-derived cell lines described here are representative of glioma lines in their general characteristics. D-259 MG retains numerous double minute chromosomes (DMs), D-263 MG contains two marker chromosomes with breaks in 9p, and D-247 MG and D-245 MG with stemlines containing 96 and 89 chromosomes contain eight and six normal copies (respectively) of chromosome No. 7. The retention in these four cell lines of the most common chromosomal abnormalities seen in biopsies of malignant human gliomas provides the opportunity to investigate the meaning of these specific chromosomal changes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartram CR, de Klein A, Hagemeijer A, Grosveld G, Heisterkamp N, Groffen J (1984) Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. Blood 63:223–225
Biegel JA, Bigner SH, Leslie DS, Bigner DD (1986) Hydroxyurea synchronization of human glioma cell lines. J Neurooncol 4:95
Bigner DD, Bigner SH, Wikstrand CJ, Ponten J, Westermark B, Mahaley MS, Ruoslathi E, Herschman H, Eng LF (1981) Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201–229
Bigner SH, Mark J, Mahaley MS, Bigner DD (1984) Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 101:103–113
Bigner SH, Mark J, Bullard DE, Mahaley MS Jr, Bigner DD (1986a) Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22:121–135
Bigner SH, Mark J, Bigner DD (1986b) Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro. Cancer Genet Cytogenet (in press)
Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD (1983) A human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43:2796–2806
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bullard DE, Schold C, Bigner SH, Bigner DD (1981) Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neurol 40:410–427
Carrel S, de Tribolet N, Mach JP (1982) Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. Acta Neuropathol (Berl) 57:158–164
Chilcote RR, Brown E, Rowley JD (1985) Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med 313:286–291
Dranoff G, Elion GB, Friedman HS, Campbell GL, Bigner DD (1985a) Influence of glutamine on the growth of human glioma and medulloblastoma in culture. Cancer Res 45:4077–4081
Dranoff G, Elion GB, Friedman HS, Bigner DD (1985b) Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma. Cancer Res 45:4082–4086
Eng LF, DeArmond SJ (1983) Immunochemistry of the glial fibrillary acidic protein. In: Zimmerman HM (ed) Progress in neuropathology, vol 5. Raven Press, New York, pp 19–39
Friedman HS, Schold SC Jr, Varia M, Bigner DD (1983) Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice. Cancer Res 43:3088–3093
Gebhardt R, Mecke D (1979) The role of growth hormone, dexamethasone and trijodothyronine in the regulation of glutamine synthetase in primary cultures of rat hepatocytes. Eur J Biochem 100:519–525
Gebhardt R, Williams GM (1986) Amino acid transport in established adult rat liver epithelial cell lines. Cell Biol Toxicol 2 (in press)
Hagemeijer A, Hahlen K, Sizoo W, Abels J (1982) Translocation (9;11) (p21;q23) in three cases of acute monoblastic leukemia. Cancer Genet Cytogenet 5:95–105
Kondo I, Shimizu N (1983) Mapping of the human gene for epidermal growth factor receptor (EGFR) on the p13→q22 region of chromosome 7. Cytogenet Cell Genet 35:9–14
Kowalczyk J, Sandberg AA (1983) A possible subgroup of ALL with 9p-. Cancer Genet Cytogenet 9:383–385
Kurtzberg J, Hershfield MS (1985) Determinants of deoxyadenosine toxicity in hybrids between human T and B lymphoblasts: a model for the development of drug resistance in T cell acute lymphoblastic leukemia. Cancer Res 45:1579–1587
Lampson LA, Levy R (1980) Two populations of Ia-like molecules on a human B cell line. J Immunol 125:203–209
Lan MS, Finn OJ, Fernsten PD, Metzgar RS (1985) Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res 45:305–310
Liberman TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H (1984) Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44:753–760
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waerfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313:133–147
McComb RD, Bigner DD (1985) Immunolocalization of laminin in neoplasms of the central and peripheral nervous systems. J Neuropathol Exp Neurol 44:242–253
McGarrity GJ (1982) Detection of mycoplasmal infections of cell cultures. In: Marmorosch K (ed) Advance in cell culture. Academic Press, New York, pp 99–131
Ovejera AA, Houchens PD, Barker AD (1978) Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 8:385–393
Pegram CN, Eng LF, Wikstrand CJ, McComb RD, Lee Y-L, Bigner DD (1986) Monoclonal antibodies reactive with epitopes restricted to glial fibrillary acidic proteins of several species. Neurochem Pathol 3:119–138
Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312–1319
Reinherz EL, Morimoto C, Fitzgerald KA, Hursey RE, Daley JA, Schlossman SF (1982) Heterogeneity of human T4+ inducer T cells as defined by a monoclonal antibody that delineates two functionally distinct subpopulations. J Immunol 128:463–471
Richter A (1970) Improved medium for the cultivation of differentiated linear cells. In Vitro 6:220–221
Seabright M (1971) A rapid banding technique for human chromosomes. Lancet ii:971–972
Schnegg JF, Diserens AC, Carrel S, Accolla RS, DeTribolet N (1981) Human glioma-associated antigens detected by monoclonal antibodies. Cancer Res 41:1209–1213
Seeger RC, Danon YL, Rayner SA, Hoover F (1982) Definition of a THY-1 determinant of human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol 128:983–989
Trent JM, Olson S, Lawn RM (1982) Chromosomal localization of human leucocyte, fibroblast, and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79:7809–7813
Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470–473
Wikstrand CJ, Bigner DD (1982) Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies. Cancer Res 42:267–275
Wikstrand CJ, Bourdon MA, Pegram CN, Bigner DD (1982) Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin: gliomas, neuroblastomas, and melanomas. J Neuroimmunol 3:43–62
Wikstrand CJ, Bigner SH, Bigner DD (1984) Characterization of three monoclonal antibodies (MCA) raised against the human glioma cell line D-54 MG. J Neuroimmunol 6:169–186
Wikstrand CJ, Grahamm FC, McComb RD, Bigner DD (1985) Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. J Neuropathol Exp Neurol 44:229–239
Wikstrand CJ, Humphrey PA, Bullard DE, Bigner DD (1986) Characterization of localizing glioma-reactive monoclonal antibodies (MAbs). J Neurooncol 4:107
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. F. Seitelberger on the occasion of his seventieth birthday
Supported on part by P01 NS0023 from the National Institute of Neurological and Communicative Disease and Stroke, R01 CA11898 from the National Cancer Institute and The Swedish Cancer Society
Rights and permissions
About this article
Cite this article
Bigner, S.H., Friedman, H.S., Biegel, J.A. et al. Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas. Acta Neuropathol 72, 86–97 (1986). https://doi.org/10.1007/BF00687952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00687952